Software Development
Events / NET/WORK / Roundups / Technical.ly

Vanguard, CSC and Chatham Financial are hiring at NET/WORK Delaware. Will you be there?

Get your plans set for our NET/WORK tech jobs fair on March 20.

NET/WORK 2018. By Dominique Nichole
This story's headline has been updated. (2/19, 10:25 a.m.)

You’re just a month away from finding the job of your dreams. We’ve already signed on our first companies for our NET/WORK tech jobs fair in Delaware and expect more to join the event before it takes place in March.

It’s all going down at CSC where you can get your resume reviewed, grab yourself a new professional headshot for that LinkedIn profile you’ve been meaning to update, and even stay afterward for a drink and some light snacks.

NET/WORK has become the go-to for jobseekers looking for the next step of their career journey. It’s happening March 20 and we’re here to update you on which local tech companies and startups are slated to be at the event.

Here’s the current list of hiring organizations coming to NET/WORK to find great talent:

You bring the enthusiasm, we’ll bring the jobs.

And a big thanks to CSC, our host, and Chatham Financial, which are going the extra mile as sponsors and are looking for smart people to join their growing teams!

Get your tickets for NET/WORK Delawarehttps://js.hscta.net/cta/current.js hbspt.cta.load(2084427, ‘2d8e7768-1fd1-459e-8818-d3d095ceb50e’, {});

Grow and accelerate your pipeline. Exhibit at NET/WORKhttps://js.hscta.net/cta/current.js hbspt.cta.load(2084427, ’38b6c238-3b56-4a37-bd3a-585362f3419a’, {});

If you’re looking for opportunities in other communities, we’re hosting NET/WORK in four cities this year:

Engagement

Join the conversation!

Find news, events, jobs and people who share your interests on Technical.ly's open community Slack

Trending

What company leaders need to know about the CTA and required reporting

How venture capital is changing, and why it matters

Why the DOJ chose New Jersey for the Apple antitrust lawsuit

Delaware Money Moves: Incyte and AstraZeneca put billions into cancer pharm acquisitions

Technically Media